pjdog

AKS 5 year Linear Regression--stock to double by year end 2017

Long
NYSE:AKS   None
Business model has changed. No more "tons for fun". Impressive secular climb GM and EBITDA based on contract based revenue vs. volatile spot market.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.